The purchase price, and that is confidential and was negotiated for all in all , 300 zillion doses, is a little less than the $19.50 per shot the United States agreed to buy a very first shipment of hundred million doses of the same vaccine, in line with what Reuters reported in November.
The EU booklet dated Nov. eighteen was circulated internally following the EU announced its supply offer with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is actually anticipated to decide on Monday on approval for the Pfizer vaccine following the photo was authorised in a few countries, like Britain as well as the United States.
On Thursday Belgian state secretary for the budget Eva De Bleeker printed on Twitter a dining room table with price tags Belgium will shell out pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the content shortly after publishing.
In that dinner table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) a dose, top many to think this was the total fee agreed by way of the EU.
Other vaccines in the table were also shown with prices lower compared to prices disclosed by EU solutions.
“There is always a full price along with a cost after delivery,” an EU official required in talks with vaccine makers told Reuters when directed to clarify the difference between the EU and Belgian prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker said Belgium’s budgeted costs were still partial.
Under EU advance purchase deals for COVID-19 vaccines, the bloc concurs upfront payments with companies to secure doses before they are approved. After approvals, EU governments are able to pay the remainder to buy reserved doses.
The EU hasn’t revealed the upfront payment agreed with Pfizer.
But, it stated in October which it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for their shots, with an additional 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Moderna and Curevac.
It has since agreed source deals with all 6 businesses and it is negotiating a seventh understanding with Novavax.